Font size
WorksheetsCancer II
Total questions: 47
Worksheet time: 27mins
subpopulation of malignant cells which:
detach from parent neoplasm
spread to distant site
formed by secondary mass & spread
Metastasis
primary neoplasm
secondary neoplasm
may be discovered first
histologically resemble primary neoplasm
Metastasis
primary neoplasm
secondary neoplasm
______ survive even when primary tumor has been eradicated
metastases
tumor
cancer
Pathway of Metastatic Spread
"seeding"
spread throughout body fluids
typically within peritoneal area
concerning when surgically removing
Body Cavity
Lymphatic Channels
Blood
Pathway of Metastatic Spread
most common route
for distant metastases
little mechanical resistance to penetrate
Body Cavity
Lymphatic Channels
Blood
Pathway of Metastatic Spread
detach from node & enter efferent vessels
may growth into noticeable lump
Body Cavity
Lymphatic Channels
Blood
Pathway of Metastatic Spread
rate of spread & growth of tumor is correlated with vascularity
Body Cavity
Lymphatic Channels
Blood
Malignant cells are capable of
continuous shed & migration through blood stream
finding their way to blood stream without producing metastasis
to successfully form secondary neoplasm, cancer cells must:
avoid immune cells
SATA
in metastatic distribution, majority of cancer cells are not able to metastasize because:
some takes place in capillary network downstream
influence of environment surrounding secondary organ
organ tropism
not enough blood supply
stimulates inappropriate growth / activity
only needs ONE mutation
Proto-oncogenes
Tumor Suppressor gene
Dominant Mutation
Recessive mutation
prevents the arrest of the cell cycle
produce proteins that inhibit growth, enhance differentiation, promote DNA repair & apoptosis
BOTH Copies must be mutated
Proto-oncogenes
Tumor Suppressor gene
Dominant Mutation
Recessive mutation
tumor formed by proto-oncogenes mutation
(a)
conveys growth factor signal to nucleus
single amino acid change
once activated, RAS always covey message to nucleus to divide
RAS protein
TP53
p53
BRCA1/2
found in about 30% of human cancer
RAS protein
TP53
p53
BRCA1/2
found in about more than 50% of human cancer
RAS protein
TP53
p53
BRCA1/2
produce suppressor gene responsible in activating
DNA repair, growth inhibition, apoptosis
RAS protein
TP53
p53
BRCA1/2
suppressor gene known to be mutated in breast cancer
RAS protein
TP53
p53
BRCA1/2
most human cancer can ONLY arise because of prior exposure to carcinogens
True
False
which cells are inherited when mutated
somatic
germinal
Cancer Screening can be performed through:
Observation,
palpation
imaging
skin tests,
saliva tests
blood test
cytologic and histologic test
In Cancer screening, which is an example of Tumour markers?
detection of new and level change of protein
effusion
increased lymph nodes
microscopic analysis of body secretion/ scrapings
Pap Test
Tissue Biopsy
Immunohistochemistry
removal of tissue specimen for microscopic study
Pap Test
Tissue Biopsy
Immunohistochemistry
use antibiotics to identify cell products or surface markers
Pap Test
Tissue Biopsy
Immunohistochemistry
In Gompertzian Growth Curve, growth plateau in 2 years is shown. What are the possible reasons for it:
low nutrients, angiogenesis, space
increased wastes
metastasis threshold is reached
treatment is working
what are the roles of surgery in caner management?
Cosmetic improvements in patients.
Diagnosing infections unrelated to cancer.
Diagnosis, prognosis, prevention, treatment, & management
Primarily used for chemotherapy administration.
Enhancing radiation therapy effectiveness.
what's the difference between INCISIONAL and EXCISIONAL biopsy?
Aside from removing large tumours, Surgery can be an option to:
prevent local recurrence
de-bulk
palliation
emergency and rehabilitation
lengthen treatment plan
useful for 50-60% of all cancer patients
benefits & side effects limited to areas being treated
chemotherapy
radiotherapy
Palliative Radiotherapy
Hormone Therapy
Immunotherapy
30+ doses use to minimize damage to healthy cells & chance of cell diciding
typically used:
in vital, inaccessible areas
with combination with surgery
chemotherapy
radiotherapy
Palliative Radiotherapy
Hormone Therapy
Immunotherapy
used to treat forms of cancer that are:
-widespread
-rapidly growing
-high risk of micro-metastatic deposits
combined with drugs used for diff mechanisms
chemotherapy
radiotherapy
Palliative Radiotherapy
Hormone Therapy
Immunotherapy
used for painful bone and soft tissue metastases
brain metastases
malignant spinal cord compression
airway obstruction, ulcerating, bleeding lesions
chemotherapy
radiotherapy
Palliative Radiotherapy
Hormone Therapy
Immunotherapy
goal is to slow cancer growth by altering hormonal environment through hormone suppression/receptor changes
chemotherapy
radiotherapy
Palliative Radiotherapy
Hormone Therapy
Immunotherapy
one of the issue for this treatment is, cancer become resistant later
chemotherapy
radiotherapy
Palliative Radiotherapy
Hormone Therapy
Immunotherapy
attempt to increase body's own immune response to cancer
chemotherapy
radiotherapy
Palliative Radiotherapy
Hormone Therapy
Immunotherapy
non-specific treatment with attenuated bacterial strains to stimulate immune system
Active Immunotherapy
Passive Immunotherapy
transfer sensitized NK Cells, T CELLS, Cytokines,
transfer antibodies into patient
Active Immunotherapy
Passive Immunotherapy
form of treatment that works against melanoma
create an environment that is hostile to tumor evolution
(a)
interferons are
anti-proliferative
pro-apoptotic
immunostimulant
anti-angiogenic
anapilactic suppressor
chemo rounds and cycles kills the same ___ each time.
same percentage but not number of cells
same numbers of cells but not percentage of cells
equivalent number of cells and percentage
target vital cellular machinery
metabolic pathways required for cells
cytotoxic drugs
chemotherapeutic agents
therapeutic index
interferes with synthesis/ function of DNA
more toxic to proliferating cells
cytotoxic drugs
chemotherapeutic agents
therapeutic index
amount of drug required to kill cancer cells
effective dose vs. toxic dose
cytotoxic drugs
chemotherapeutic agents
therapeutic index
chemo has a ____ therapeutic index
LOW
HIGH
most therapies target rapidly dividing cells except
what are examples of most targeted common dividing cells during therapy?
Bone marrow, GI Tract, Hair Skin, Reproductive System
Liver cells, Skin cells, Nerve cells
GI Tract, Nail Skin, Endocrine System, Bone marrow,
